The expression of CYSLTR2 has also significantly been downregulated in multiple myeloma [38], melanoma [39], and colorectal cancer [34], which reveals its tumor suppressor function in other cancers also. This evidence concerns the gene CYSLTR2 and plasma cell myeloma.